Loratadyna (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Loratadyna" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
924th place
75th place

doi.org

dx.doi.org

  • James W. Slater, Andrew D. Zechnich, Dean G. Haxby, Second-Generation Antihistamines. A Comparative Review, „Drugs”, 57 (1), 1999, s. 31–47, DOI10.2165/00003495-199957010-00004, PMID9951950 (ang.).
  • R. Leurs, M.K. Church, M. Taglialatela, H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects, „Clinical & Experimental Allergy”, 32 (4), 2002, s. 489–498, DOI10.1046/j.0954-7894.2002.01314.x, PMID11972592 (ang.).
  • F. Estelle R. Simons, H1-Antihistamines. More relevant than ever in the treatment of allergic disorders, „The Journal of Allergy and Clinical Immunology”, 112 (4), 2003, s. S42–S52, DOI10.1016/S0091-6749(03)01876-1, PMID14530788 (ang.).
  • Francesca Levi-Schaffer, Ron Eliashar, Mast Cell Stabilizing Properties of Antihistamines, „Journal of Investigative Dermatology”, 129 (11), 2009, s. 2549–51, DOI10.1038/jid.2009.256, PMID19826448 (ang.).
  • Gailen D. Marshall jr., Therapeutic options in allergic disease: Antihistamines as systemic antiallergic agents, „The Journal of Allergy and Clinical Immunology”, 106 (5), 2000, s. S303–S309, DOI10.1067/mai.2000.110165, PMID11080746 (ang.).
  • Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, „The Journal of Allergy and Clinical Immunology”, 108 (5), 2001, s. S147–S334, DOI10.1067/mai.2001.118891, PMID11707753 (ang.).
  • Anima Ghosal i inni, Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites, „Drug Metabolism Letters”, 3 (3), 2009, s. 162–170, DOI10.2174/187231209789352067, PMID19702548 (ang.).

nih.gov

ncbi.nlm.nih.gov

  • James W. Slater, Andrew D. Zechnich, Dean G. Haxby, Second-Generation Antihistamines. A Comparative Review, „Drugs”, 57 (1), 1999, s. 31–47, DOI10.2165/00003495-199957010-00004, PMID9951950 (ang.).
  • R. Leurs, M.K. Church, M. Taglialatela, H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects, „Clinical & Experimental Allergy”, 32 (4), 2002, s. 489–498, DOI10.1046/j.0954-7894.2002.01314.x, PMID11972592 (ang.).
  • F. Estelle R. Simons, H1-Antihistamines. More relevant than ever in the treatment of allergic disorders, „The Journal of Allergy and Clinical Immunology”, 112 (4), 2003, s. S42–S52, DOI10.1016/S0091-6749(03)01876-1, PMID14530788 (ang.).
  • Francesca Levi-Schaffer, Ron Eliashar, Mast Cell Stabilizing Properties of Antihistamines, „Journal of Investigative Dermatology”, 129 (11), 2009, s. 2549–51, DOI10.1038/jid.2009.256, PMID19826448 (ang.).
  • Gailen D. Marshall jr., Therapeutic options in allergic disease: Antihistamines as systemic antiallergic agents, „The Journal of Allergy and Clinical Immunology”, 106 (5), 2000, s. S303–S309, DOI10.1067/mai.2000.110165, PMID11080746 (ang.).
  • Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, „The Journal of Allergy and Clinical Immunology”, 108 (5), 2001, s. S147–S334, DOI10.1067/mai.2001.118891, PMID11707753 (ang.).
  • M.S. Ashenager i inni, Inhibition of Cytokine-Induced Expression of T-cell Cytokines by Antihistamines, „Journal of Investigational Allergology and Clinical Immunology”, 17 (1), 2007, s. 20–26, PMID17323859 (ang.).
  • J.M. Negro-Alvarez i inni, Antiallergic properties of antihistamines, „Allergologia et Immunopathologia”, 24 (4), 1996, s. 177–183, PMID8939275 (ang.).
  • Anima Ghosal i inni, Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites, „Drug Metabolism Letters”, 3 (3), 2009, s. 162–170, DOI10.2174/187231209789352067, PMID19702548 (ang.).

sigmaaldrich.com